It’s a complicated subject matter that’s probably best described by the experts:
“Nanotechnology is the understanding and control of matter at the nanoscale, at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at this length scale.”
So what does that mean in practice? Biotech companies deal heavily in nanotechnology, looking at chemical reactions on a tiny scale and manufacturing new chemicals to alter those reactions. Companies like Inovio (INO) depend on it to create and test their products.
Whether all of this technology is a good thing depend on your personality, and probably how much science fiction you’ve read. But there’s no denying that we’ve launched ourselves into a tech-fueled future.
Adam Benjamin is an Assistant Editor of InvestorPlace. As of this writing, he did not hold a position in any of the aforementioned securities.